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Objectives. The relation between endotbelium-dependent vaso- 
dilator function in the brachial and coronary arteries was deter- 
mined in the same subjects. 
Background. Coronary artery endothelial dysfunction precedes 
the development of overt atherosclerosis and is important in its 
pathogenesis. A noninvasive assessment of endothelial function in 
a peripheral conduit vessel, the brachial artery, was recently 
described, but the relation between brachial artery function and 
coronary artery vasodilator function has not been explored. 
Methods. In 50 patients referred to the catheterization labora- 
tory for the evaluation of coronary artery disease (mean age -+ SD 
56 -+ 10 years), the coronary vasomotor response to serial 
intracoronary infusions of the endothelium-dependent agonist 
acetylcholine (10 -s to 10 -4 tool/liter), was studied. Endothelium- 
dependent vasodilation was also assessed in the brachial artery by 
measuring the change in brachial artery diameter in response to 
reactive hyperemia. 
Results. Patients with coronary artery endothelial dysfunction 
manifested as vasoconstriction i  response to acetylcholiue had 
significantly impaired flow-mediated vasodilation in the brachial 
artery compared with that of patients with normal coronary 
endothelial function (4.8 _+ 5.5% vs. 10.8 _+ 7.6%, p < 0.01). 
Patients with coronary artery disease also had an attenuated 
brachial artery vasodilator esponse compared with that of pa- 
tients with angiographically smooth coronary arteries (4.5 -+ 4.6% 
vs. 9.7 -+ 8.1%, p < 0.02). By multivariate analysis, the strongest 
predictors of reduced brachial dilator responses to flow were 
baseline brachial artery diameter (p < 0.001), coronary endothe- 
lial dysfunction (p = 0.003), the presence of coronary artery 
disease (p = 0.007) and cigarette smoking (p = 0.016). The 
brachial artery vasodilator esponse to sublingual nitroglycerin 
was independent of coronary endothelial responses or the pres- 
ence of coronary artery disease. The positive predictive value of 
abnormal brachial dilation (<3%) in predicting coronary endo- 
thelial dysfunction is 95%. 
Conclusions. This study demonstrated a close relation between 
coronary artery endothelium-dependent vasomotor esponses to 
acetyicholine and flow-mediated vasodilation in the brachial 
artery. This noninvasive method may become a useful surrogate in 
assessing the predisposition to atherosclerosis in patients with 
cardiac risk factors. 
(J Am Coll Cardioi 1995;26:1235-41) 
Endothelial dysfunction plays a pivotal role in the pathogenesis 
and clinical manifestations of atherosclerosis because the 
normal endothelium has lost its abilit 3' to prevent abnormal 
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vasoconstriction a d to inhibit platelet aggregation and smooth 
muscle cell proliferation (1,2). In humans, the coronary vaso- 
dilator response to infused agonists uch as acetylcholine can 
be measured in the catheterization laboratory and this proce- 
dure is now an accepted method of assessing endothelium- 
dependent vasomotor function (3-5). The dilator response to 
acetylcholine incoronary conduit vessels was recently shown to 
be mediated by nitric oxide (6). Patients with risk factors for 
coronary artery disease or overt atherosclerosis have paradoxic 
constriction i  response to acetylcholine ( ndothelial dysfunc- 
tion), readily distinguishing them from patients with a normal 
endothelium, who have a dilator response (3,7,8). Because 
endothelial dysfunction precedes the development of clinical 
atherosclerosis, it would be desirable to identify and treat 
endothelial dysfunction before atherosclerosis develops (9). 
However, because the method of assessing coronary endothe- 
lial function is invasive and time consuming, it cannot easily be 
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repeated or performed before coronary angiography becomes 
clinically necessary. 
The vasodilator response in conduit arteries to an increase 
in blood flow is thought to be endothelium dependent (10-13). 
This flow-mediated ilation has been demonstrated in the 
epicardial coronary arteries and in the peripheral conduit 
vessels by intraarterial infusion of vasodilators. Recently, high 
resolution ultrasound has been used to assess brachial artery 
flow-mediated vasodilator esponses noninvasively (14). This 
technique isboth sensitive and reproducible. Preliminary data 
using this technique have demonstrated animpairment in the 
vasodilator response of the brachial artery response in patients 
with atherosclerosis or cardiac risk factors (14-16). Because 
the brachial artery rarely develops tructural changes typical of 
coronary atherosclerosis, t was unclear whether this brachial 
artery vasodilator response is related to coronary endothelial 
function. The purpose of the present study was to compare the 
endothelium-dependent vasomotor function in the brachial 
and coronary arteries in the same patients with various degrees 
of coronary atherosclerosis. 
Methods 
Patients. The study group consisted of 50 consecutive 
patients referred to the cardiac atheterization laboratory who 
underwent coronary, endothelial function testing and also 
agreed to a brachial ultrasound study. The patients ranged in 
age from 35 to 73 years (mean : SD 56 _+ 10), and 19 (38%) 
were female. Cardiac risk factors were present as follows: 
cigarette smoking in 7 patients (14%), hypertension i 22 
(44%), hypercholesterolemia in 40 (80%), diabetes mellitus in 
2 (4%) and a family history, of premature atherosclerosis in 18 
(36%). The mean number of risk factors was 1.3 ± 1.1. 
Coronary artery disease, defined as lumen irregularities or 
stenoses, was present in 32 patients (64%): the remaining 18 
patients had entirely normal-appearing coronary arteries on 
angiography. Written informed consent was obtained from 
patients before the catheterization procedure in accordance 
with the guidelines established by the Committee for the 
Protection of Human Subjects at our institution. 
Cholesterol-lowering drug therapy was used by 26 (52%) of 
the patients in the study. The total and low (LDL) and high 
(HDL) density lipoprotein cholesterol values were 173 ± 38, 
103 _+ 34 and 39 _+ ll mb/dl, respectively, atthe time of the 
study. 
Study protocol. Corona~' endothelial function study. Pa- 
tients' long-acting vasoactive medications including calcium 
channel blockers, beta-adrenergic blocking agents, nitrates and 
converting enzyme inhibitors were discontinued for ->18 h 
before the catheterization. After diagnostic right and left heart 
catheterization, patients were eligible to receive vasoactive 
drugs if there were no stenoses >50% in a study vessel (either 
the left anterior descending or the left circumflex coronary 
artery). 
After a 7F or 8F guiding catheter was positioned in the left 
main coronary artery and 10.000 IU of heparin was infused, a 
2.5F infusion catheter was advanced through the guiding 
catheter over a 0.014-in. (0.036-cm) guide wire into the prox- 
imal portion of the left anterior descending or left circumflex 
coronary artery. Serial intracoronary infusions were made 
according to an established protocol: 1) control infusion (5% 
dextrose in water); 2) serial 2.5-rain infusions of the endothelium- 
dependent vasodilator acetylcholine (Miochol, Iolab Pharma- 
ceuticals) in doses of 0.16, 1.6 and 16 p~g/min, achieving final 
estimated intracoronary concentrations of 10 -s, 10 -7 and 10 -6 
tool/liter; 3) 5-rain recontrol infusion of 5% dextrose in water; 
4) 3-min infusion of the endothelium-independent vasodilator 
nitroglycerin at 16 tzg/min (3). During each infusion, the blood 
pressure, heart rate and electrocardiogram (ECG) were con- 
tinuously monitored. 
Quantitative coronary angiographic mages were taken af- 
ter each intervention by a previously validated method (3,17). 
A nonionic ontrast medium (iohexol [Omnipaque], Winthrop 
Laboratories) was injected into the left coronary artery at 
7 ml/s for a total of 9 ml with a power injector (Medrad) to 
opacify the coronary artery. 
Brachial endothelial function study. The brachial artery 
protocol was completed within 24 h of the coronary artery 
study in 39 patients (78%). The remaining patients returned 
for study within 4 weeks. Vasoactive medications were held for 
~18 h before the study in all patients. 
Brachiai artery vasodilator responses were measured in the 
dominant arm of patients by a previously validated and repro- 
ducible technique (14,15,18). A 7.5-MHz linear phased array 
ultrasound transducer attached to a Toshiba ultrasound ma- 
chine was used to image the brachial artery longitudinally just 
above the antecubital fossa. The intraobserver and interob- 
server variability for repeated measurements are 0 -+ 0.07 mm 
and 0.05 _+ 0.16 mm, respectively, in our laboratory. When 
reactive hyperemia studies are performed on 2 separate days, 
the mean difference in brachial vasodilator response in abso- 
lute terms is 1.0 _+ 2.0%. 
After baseline measurements of brachial artery diameter 
were recorded, a blood pressure cuff was inflated on the 
proximal portion of the arm to 200 mm Hg for 5 rain, creating 
distal limb ischemia. After release of the cuff, reactive hyper- 
emia occurs, that is, flow in the brachial artery increases to 
accommodate he dilated resistance vessels in the forearm. 
The brachial artery was imaged for the 1st 2 min of reactive 
hyperemia. The flow-mediated dilator esponse was used as a 
measure of endothelium-dependent vasodilation. The brachial 
artery diameter was allowed to return to baseline level (-5 min 
after cuff release). Then, 0.4 mg of nitroglycerin was given 
sublingually, and the brachial artery was imaged for the 
ensuing 3 min to measure peak diameter. The response to 
nitroglycerin is a measure of endothelium-independent vaso- 
dilation. 
Analysis. Quantitative coronary angiography. Technically 
suitable single-plane angiograms were selected for computer 
analysis on the basis of a previously described method (3,17). 
An automated edge detection program was used to search 
densities and seek inflection points, thus measuring the seg- 
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ment diameter of the vessel along the length of the selected 
segment (ImageComm, Quantum IC software). Two segments 
8 to 10 mm in length were selected for analysis prospectively on
the basis of optimal regions for quantitative angiographic 
analysis. The vasomotor responses for the two segments in 
each patient were averaged to create a mean vasodilator 
response to acetylcholine and nitroglycerin. This average re- 
sponse was used to evaluate the relation between the magni- 
tude of the coronary and brachial artery vasomotor responses 
in a continuous fashion. 
For the purpose of classifying the coronary vasomotor 
response dichotomously, patients in whom either of the two 
coronary segments constricted significantly (>5% from base- 
line) were classified as having coronary endothelial dysfunc- 
tion. All other patients were considered to have normal 
coronary endothelial function. The vasomotor response to 
acetylcholine was also compared with brachial responses in a 
continuous manner. 
The coronary angiograms were coded for atherosclerosis 
after review by an observer who had no knowledge of the data 
on brachial artery vasodilator function. Only patients whose 
epicardial coronary arteries were completely smooth were 
classified as having no angiographic coronary disease. 
Brachial vasodilator esponses. Three sequential systolic 
frames (taken at the end of the T wave on the ECG) for each 
intervention (baseline, reactive hyperemia, repeat baseline and 
nitroglycerin) were digitized, with use of a Rasterops analog to 
digital converting board, into a Macintosh computer. Straight 
segments of the artery (10 mm in length) were chosen. The 
blood-intima interface was determined for the posterior por- 
tion of the artery and the blood-media border for the anterior 
surface (unless intima was clearly identified). A software 
algorithm automatically calculated the average diameter ( 15 to 
20 points) over the selected segment. The three frames were 
then averaged for each intervention. Previous studies have 
shown that maximal dilation occurs 1 rain after cuff deflation 
for reactive hyperemia and 3 min after sublingual nitroglycerin 
(18). Measurements were taken at these times. The end point 
was the percent diameter change of the brachial artery in 
response to reactive hyperemia or nitroglycerin. The results 
did not differ when they were also analyzed by using the 
absolute change in brachial diameter or brachial area. Only the 
data for percent diameter change are shown. 
Statistics. Differences between clinical characteristics, and 
brachial artery vasodilator responses were evaluated and ana- 
lyzed by unpaired t tests for two-group comparisons and 
one-way analysis of variance for multiple group comparisons. 
Post hoc testing was performed by using a Bonferroni correc- 
tion. Linear regression analysis was used to compare the 
continuous relation between brachial artery and corona~ 
artery responses. Predictors of brachial artery vasodilator 
responses to reactive hyperemia were obtained by forward 
stepwise multilinear regression analysis. Previous tudies (14) 
have demonstrated that the percent brachial artery diameter 
change to reactive hyperemia is inversely correlated with the 
baseline diameter and, as such, this variable was included in 
Table l. Clinical Characteristics of the Study Patients 
Normal Coronary 
Endothelial Function Coronary Endothelial 
(n - 13) Dysfunction (n = 37) 
Age (yr) 58 _+ 8 55 - 10 
Male/female (no.) 4/9* 27/10" 
Total cholesterol (mg/dl) 168 ± 38 175 _+ 38 
LDL cholesterol (mg/dl) 103 ± 36 102 _+ 34 
HDL cholesterol (mg/dl) 41 ± 13 38 _+ 11 
Cigarette users 4 (31%) 3 (8%) 
Hypertension 6 (46%) 16 (43%) 
Diabetes mellitus 1 (8%) 1 (3%) 
Risk factors (no.) 1.4 _+ 1.4 1.2 _+ 0.9 
*p < 0.05. Unless otherwise indicated, data presented are mean value +_ SD 
or number (%) of patients. HDL - high densit 3'lipoprotein; LDL = low density 
[ipoprotein. 
the stepwise model. Statistical significance was defined as a 
two-sided p value < 0.05. The data are expressed as the mean 
value _+ SD. 
Results  
Coronary artery endothelial function. Patients were sepa- 
rated into two groups on the basis of their coronary epicardial 
vasomotor response to acetylcholine. Normal coronary endo- 
thelial function was present in 13 patients (26%); the remain- 
ing 37 (74%) demonstrated ndothelial dysfunction. Patients 
with preserved endothelial function demonstrated dilation by 
9 _+ 11% in response to the maximal dose of acetylcholine, 
whereas those with endothelial dysfunction demonstrated con- 
striction by 17 _+ 14%. The coronary vasodilator response to 
the endothelium-independent agonist nitroglycerin was not 
significantly different between the two groups (17 _+ 10% vs. 
22 _+ 16%). There were more women in the group with normal 
coronary endothelial function. However, no other differences 
were present between the two groups in terms of clinical 
characteristics or cardiac risk factors (Table 1). 
Brachial artery endothelial function. The change in bra- 
chial artery diameter in response to reactive hyperemia in all 
patients ranged from -2% to 25%. There was a significant 
inverse relation between the degree of dilation and the base- 
line vessel diameter, as has been previously reported (r = 
-0.47, p < 0.01). 
The brachial artery vasodilator response to reactive hyper- 
emia was significantly greater in the patients with normal 
coronary, endothelial function than in those with coronary 
endothelial dysfunction (10.8 -- 7.6% vs. 4.8 +__ 5.5%, p < 
0.01). In contrast, he brachial artery response to nitroglycerin 
did not differ between these two groups (11.5 _+ 5.9% vs. 
10.6 _+ 5.7%) (Fig. 1). There was no difference in the baseline 
brachial artery diameter to account for these differences (4.0 _+ 
0.7 mm vs. 3.9 _+ 0.5 mm). If the normal brachial dilator 
response to reactive hyperemia was arbitrarily set at >3% 
(1 SD below the mean value in the normal endothelial function 
group), then 18 (95%) of 19 patients with an abnormal brachial 
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Figure 1. Bar graph comparing the percent change in brachial artery" 
diameter in response to reactive hyperemia (left) and sublingual 
nitroglycerin (right) in patients without (solid bars) and with (hatched 
bars) coronary endothelial dysfunction. Brachial vasodilation issignif- 
icantly greater in response to reactive hyperemia (endothelium- 
dependent s imulus) than to nitroglycerin (endothelium-independent 
stimulus) in the patients with normal coronary endothelial function. 
*p < 0.01. 
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Figure 3. Graph demonstrating the percent change in brachial artery 
diameter in response to reactive hyperemia in three patient groups. 
Patients with no coronary disease and normal endothelial function 
(solid bar) had a greater response than did patients with both coronary 
disease and endothelial dysfunction (open bar) and tended to have a 
better esponse than did patients with coronary endothelial dysfunc- 
tion without overt coronary atherosclerosis (hatched bar). *p = 0.08, 
**p < 0.001 versus patients with no coronary disease and normal 
endothelial function. 
response (<3%) had coronary endothelial dysfunction (posi- 
tive predictive value). However, only 12 (39%) of 31 patients 
with brachial dilation >3% had normal coronary endothelial 
function (negative predictive value). The sensitivity of detect- 
ing patients with abnormal coronary endothelial function was 
49%, and the specificity was 92% at this cutoff value. 
Brachial artery dilator function was also compared in 
patients with and without angiographic evidence of coronary 
artery disease, irrespective of the coronary response to acetyi- 
choline. (Fig. 2) Patients with no evidence of coronary artery 
disease had significantly more brachial artery vasodilation to 
Figure 2. Bar graph comparing the percent change in brachial artery 
diameter in response to reactive hyperemia (left) and sublingual 
nitroglycerin (right) in patients without (solid bars) and with (hatched 
bars) angiographic evidence of coronary artery disease. Brachial 
vasodilation is significantly greater in response to reactive hy- 
peremia (endothelium-dependent stimulus) than to nitroglycerin 
(endothelium-independent stimulus) in patients without coronary ar- 
tery disease. *p -- 0.02. 
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reactive hyperemia than did patients with coronary artery 
disease (9.7 _+ 8.1% vs. 4.5 _+ 4.6%, p = 0.02). The baseline 
brachial artery diameter was not different in these two groups 
(4.0 _ 0.7 mm vs. 3.9 _+ 0.6 mm); the brachial artery vasodi- 
lator response to nitroglycerin was also similar in these groups. 
The interaction between coronary artery disease and coro- 
nary endothelial function was also explored. Patients with both 
coronary disease and coronary endothelial dysfunction had the 
smallest brachial artery vasodilator esponse (3.8 -+ 5.7%). 
Patients with no evidence of coronary disease but with coro- 
nary endothelial dysfunction had an intermediate response 
(7.2 _+ 5.6%). However, the patients with no angiographic 
evidence of coronary disease and normal coronary endothelial 
function had the greatest brachial artery vasodilator response 
(13.8 _+ 5.8%). (Fig. 3) The latter group had a significantly 
better esponse than the group with both coronary disease and 
endothelial dysfunction (p < 0.001) and tended to have more 
arterial dilation than the group with coronary endothelial 
dysfunction without overt atherosclerosis (p = 0.08). Again, 
the baseline brachial artery diameter was the same in the three 
groups (4.0 _+ 0.6, 4.0 _ 0.6 and 3.8 -+ 0.6 mm, respectively). 
The continuous relation between percent diameter change 
in the brachial artery in response to reactive hyperemia nd the 
percent diameter change in the coronary artery in response to 
acetylcholine is shown in Figure 4. A significant relation was 
observed (p < 0.05), but considerable scatter of the data was 
present. 
The response was compared in patients with a normal 
(<130 mg/dl) or an abnormal LDL cholesterol level. There 
was no difference in response in these two groups (6.8 _+ 6.6% 
vs. 4.4 _+ 6.0%). 
A multivariate linear regression analysis was performed to 
determine the predictors of the brachial artery vasodilator 
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Figure 4. Brachial dilator esponse toreactive hyperemia 
as a function of the coronary response toacetylcholine i  
patients without (circles) and with (squares) coronary 
artery disease (r = 0.36, p = 0.01). 
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responses. The factors that predicted an attenuated brachial 
artery response were a larger baseline diameter, abnormal 
coronary endothelial function, coronary artery disease and 
cigarette smoking. Age, gender, cardiac risk factors other than 
smoking and treatment with cholesterol-lowering therapy were 
not significant predictors in the model (Table 2). 
Discuss ion  
Previous studies have demonstrated impaired vasodilator 
responses in the brachial arteries or coronary arteries of 
patients with cardiac risk factors or overt atherosclerosis but 
not concomitantly in the same patient. The important new 
finding in this study is that endothelial function in the coronary 
artery parallels that in a peripheral conduit vessel--the bra- 
chial artery in humans. 
Endothelial dysfunction in peripheral circulation. The 
endothelium-dependent vasodilator esponse of limb resis- 
tance vessels is impaired in patients with risk factors for 
atherosclerosis (19). In patients with hypercholesterolemia or 
hypertension, for example, the flow response to infused cho- 
linergic agonists is blunted compared with that of normal 
subjects (20,21). This response has also been shown (22) to be 
dependent on nitric oxide. Thus, even though there is good 
evidence that endothelium-derived nitric oxide is important in 
controlling vascular esponsiveness in both conduit and resis- 
tance vessels in many vascular beds, studies have not been 
undertaken to study endothelial responses in more than one 
vascular bed in the same patient. Concordant responses in 
Table 2. Regression Model for Predicting Change in Brachial 
Artery, Diameter in Response toReactive Hyperemia* 
Predictors Coefficient (SE) p Value 
Baseline brachial rtery diameter 4.05 (1.16) 0.(~)1 
Coronary endothelial dysfunction - 5.39 (I .70) 0.003 
Coronary artery disease -4.43 (I.57) 0.007 
Cigarette smoking -- 5.48 (2.19) 0.016 
*Overall r - 0.686; r e - 0.47; p < 0.00(101. SE -- standard error of the 
coefficient (slope). 
coronary and peripheral vasculature might allow for less 
invasive means of endothelial function testing in patients with 
suspected coronary endothelial dysfunction. 
Noninvasive assessment of endothelial function. Recently, 
a noninvasive ultrasound technique has been described (14) for 
measuring the vasodilator responses of the brachial artery. In 
response to the increase in blood flow that occurs after 5 min 
of ischemia (upper arm occlusion), the normal brachial artery 
increases its diameter by up to 20%, with excellent reproduc- 
ibili~ (14,15). 
This flow-mediated ilation has been shown to be 
endothelium-dependent in vascular beds, in animal experi- 
ments, and this relation is likely to occur in humans as well 
(10-13). Preliminary evidence (23) suggests that the increase 
in shear stress produced by increased flow may release nitric 
oxide through activation of potassium ion channels. The 
increase in brachial artery diameter seen in response to 
reactive hyperemia can be attenuated by blocking nitric oxide 
synthase with NG-monomethyl-L-arginine (24). 
Present study. This study demonstrated that, compared 
with patients without coronary artery disease, patients with 
angiographic evidence of coronary artery disease have a 
blunted brachial dilator esponse to reactive hyperemia but not 
to nitroglycerin. We (16) previously found in small numbers of 
patients that young persons with coronary disease (<40 years 
of age) had an attenuated brachial response compared with 
that of age-matched control subjects without coronary disease 
or risk factors. Coronary endothelial responses were not 
measured in those patients. Celermajer et al. (14) also re- 
ported that patients with coronary artery disease had less 
flow-mediated brachial artery dilation than did control sub- 
jects, although the patients with coronary disease were much 
older and had higher cholesterol levels than those of the 
control subjects. That study also demonstrated a blunted 
response to nitroglycerin the patients with coronary artery 
disease compared with that of control subjects; however, this 
response was probably related to the larger baseline diameter 
brachial artery, which the investigators showed was also in- 
versely related to the dilator response to nitroglycerin. 
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The new finding in the present study is that patients with 
coronary endothelial dysfunction had a blunted brachial artery 
vasodilator response to reactive hyperemia but not to nitro- 
glycerin. This effect was independent of the influence of 
angiographic coronary artery disease. In a multivariate model, 
the presence of coronary endothelial dysfunction was the 
strongest predictor of an abnormal brachial artery vasodilator 
response after accounting for baseline brachial artery diame- 
ter. The normal brachial artery vasodilator response is intrin- 
sically linked to the baseline coronary artery diameter (14). 
The relation between the brachial and coronary vasodilator 
responses was significant, but not to the degree that the 
magnitude ofone can be used to predict he magnitude of the 
other. If 3% dilation to flow induced by reactive hyperemia was 
chosen as an arbitrary normal cutoff value, then the majority of 
patients (18 of 19) with a lower level of brachial dilation had 
coronary endothelial dysfunction. However, the sensitivity for 
detecting coronary endothelial dysfunction was only 49%. The 
use of a single cutoff value to define normal is problematic 
because of the strong inverse relation between flow-mediated 
vasodilation and baseline brachial diameter. Subjects with 
small brachial arteries may have "normal" arterial dilation 
even in the presence of endothelial dysfunction, and patients 
with very large brachial arteries may appear to have abnormal 
dilation despite normal endothelial function. At this point, this 
technique appears to be better suited to the study of small 
groups instead of individual patients, matching groups for 
baseline brachial diameters. 
In our study patients, the only cardiac risk factor associated 
with brachial endothelial dysfunction was cigarette smoking. 
Celermajer ct al. (14,15) previously showed impaired brachial 
responses in cigarette smokers and children with hypercholes- 
terolemia. Cholesterol levels were not predictive of brachial 
artery dysfunction i  the present study; however, because 52% 
of the patients had been receiving cholesterol-lowering drug 
therapy, it is possible that a relation existed but was masked by 
the therapy. The normal response to nitroglycerin i  our study 
group tends to suggest hat these patients had a selective 
endothelial dysfunction of the brachial artery rather than a 
generalized isorder of smooth muscle cell responsiveness. 
This relation strongly suggested that endothelial dysfunction is 
a generalized process and occurs in arteries that do not 
normally manifest clinical atherosclerosis. 
Previous tudies (5,7) have shown that endothelial dysfunc- 
tion precedes, and is probably important in, the pathogenesis 
of atherosclerosis. If atherosclerosis is a continuous spectrum 
from normal endothelial function to overt atherosclerosis, one 
could postulate that endothelial dysfunction is a potentially 
useful early functional expression of the disease process. The 
identification of this dysfunction, in addition to typical cardiac 
risk factors, may help identify patients at higher isk of develop- 
zing clinically significant atherosclerosis. The evidence from 
the current study suggests that brachial vasodilator function 
parallels progressive coronary endothelial dysfunction. (Fig. 3). 
Limitations of the study. Constriction >5% was used as 
the cutoff value for abnormal coronary endothelial function. 
This value is somewhat arbitrary given that endothelial dys- 
function is a continuous variable. However, if the patients are 
analyzed using 5% dilation as the cutoff value, the same results 
are obtained with differences in brachial dilation noted be- 
tween the groups. 
Ideally it would have been desirable to compare the bra- 
chial and coronary endothelial responses to the identical 
stimuli. Flow-mediated responses in the coronary bed were not 
available in these patients. There is good evidence that both 
stimuli are mediated by endothelium-derived nitric oxide, 
albeit through different mechanisms. Previous studies (13,17) 
in the coronary artery have demonstrated that acetylcholine 
vasodilator responses parallel flow-mediated vasodilation i the 
same patients. However, despite using different endothelium- 
dependent s imuli, we were clearly able to show a close relation 
between the coronary and brachial endothelial responses inthe 
same patients. 
The peak flow response to reactive hyperemia was not 
measured in this study. It has been previously shown (14) that 
peak flow may be up to 25% less in patients with coronary 
disease than in normal subjects. However, previous work by 
our group (18) has shown that a decrease of this magnitude in
peak flow will not significantly affect he flow-mediated vaso- 
dilation of the brachial artery. It is unlikely that the decreased 
dilator esponse is the result of a decreased flow stimulus. 
The study group was recruited from patients who were 
referred to the catheterization laboratory for suspected coro- 
nary artery disease. As such there were no patients in the group 
without risk factors, and the majority had evidence of endo- 
thelial dysfunction. It would be important to determine the 
relation between the coronary and brachial responses in young 
patients who might be screened with this noninvasive tech- 
nique. The youngest patient in our study was 35 years old. It is 
not known if young patients with brachial artery endothelial 
dysfunction, such as those reported by Celermajer et al. (14), 
have concomitant coronary endothelial dysfunction. However, 
because these patients do not present o the catheterization 
laboratory, it is unlikely that this information will become 
available. For now, we must assume that the good correlation 
observed in this study between coronary and brachial re- 
sponses in older patients with risk factors with or without overt 
atherosclerosis is applicable to patients at an earlier stage of 
their disease. 
Conclusions. Endothelial dysfunction is a generalized pro- 
cess and is not necessarily confined to vascular beds with 
clinically overt atherosclerosis. Using an ultrasound technique, 
we showed that the brachial vasodilator response to reactive 
hyperemia was closely related to the coronary vasodilator 
response to acetylcholine. This noninvasive t chnique could be 
a useful method of assessing arterial dysfunction before and 
during all stages in the development and treatment ofathero- 
sclerosis. 
We thank Michael Dyce for expert echnical assistance and the cardiac cathe- 
terization laboratory staff or their support and enthusiasm during this study. 
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